Compounds for enzyme inhibition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060088471A1
SERIAL NO

11254541

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like and PGPH activities of the 20S proteasome can be selectively inhibited with the inventive compounds. The peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus, such as a detectable label. Along with therapeutic utilities, these peptide based compounds can be used in assays useful for screening, monitoring, diagnostic and/or dosing purposes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTEOLIX INC333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bennett, Mark K Moraga, CA 53 603
Buchholz, Tonia J Ann Arbor, MI 12 120
Demo, Susan D San Francisco, CA 8 122
Laidig, Guy J Menlo Park, CA 51 1405
Lewis, Evan R Pacifica, CA 3 181
Smyth, Mark S Foster City, CA 74 1288

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation